A new, high‐resolution, 600‐MHz nuclear‐magnetic‐resonance spectrometer at Carnegie‐Mellon University will be ready for experimenters early in the spring. With a magnetic field almost twice that of previously available NMR spectrometers, the new spectrometer provides roughly a doubling of resolving power for the study of organic molecules. The Carnegie‐Mellon NMR Facility for Biomedical Studies (a joint undertaking of Carnegie‐Mellon and the University of Pittsburgh) has called for proposals for a first round of short experiments covering a broad spectrum of applications, to explore the capabilities of the spectrometer.

This content is only available via PDF.
You do not currently have access to this content.